Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Johnson

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Journal of Surgical Education|July 27, 2010
Relationship among United States Medical Licensing Step I, orthopedic in-training, subjective clinical performance evaluations, and american board of orthopedic surgery examination scores: a 12-year review of an orthopedic surgery residency programCharles H Crawford, John Nyland, Craig S Roberts, et al.
Journal of Texture Studies|September 27, 2017
The effect of storage temperature on blue cheese mechanical propertiesHelen S Joyner Melito, Dorothy Francis, Brooke Luzzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancerMartin H Cohen, John R Johnson, Ning Li, et al.
Evolutionary Anthropology|June 19, 2013
Sociopolitical effects of bow and arrow technology in prehistoric coastal CaliforniaDouglas J Kennett, Patricia M Lambert, John R Johnson, et al.
The Oncologist|October 27, 2007
FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphomaBhupinder S Mann, John R Johnson, Martin H Cohen, et al.
Journal of the National Cancer Institute|February 2, 2010
Review of oncology and hematology drug product approvals at the US Food and Drug Administration between July 2005 and December 2007Rajeshwari Sridhara, John R Johnson, Robert Justice, et al.
The Spine Journal : Official Journal of the North American Spine Society|November 12, 2003
Perioperative complications of lumbar instrumentation and fusion in patients with diabetes mellitusSteven D Glassman, Gary Alegre, Leah Carreon, et al.
The Oncologist|August 5, 2005
FDA drug approval summary: erlotinib (Tarceva) tabletsMartin H Cohen, John R Johnson, Yeh-Fong Chen, et al.
The Oncologist|June 22, 2005
FDA drug approval summary: pemetrexed for injection (Alimta) for the treatment of non-small cell lung cancerMartin H Cohen, John R Johnson, Yong-Cheng Wang, et al.
Oncology (Williston Park, N.Y.)|February 6, 2008
Erlotinib/gemcitabine for first-line treatment of locally advanced or metastatic adenocarcinoma of the pancreasAdrian M Senderowicz, John R Johnson, Rajeshwari Sridhara, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Journal of Surgical Education|July 27, 2010
Relationship among United States Medical Licensing Step I, orthopedic in-training, subjective clinical performance evaluations, and american board of orthopedic surgery examination scores: a 12-year review of an orthopedic surgery residency programCharles H Crawford, John Nyland, Craig S Roberts, et al.
Journal of Texture Studies|September 27, 2017
The effect of storage temperature on blue cheese mechanical propertiesHelen S Joyner Melito, Dorothy Francis, Brooke Luzzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancerMartin H Cohen, John R Johnson, Ning Li, et al.
Evolutionary Anthropology|June 19, 2013
Sociopolitical effects of bow and arrow technology in prehistoric coastal CaliforniaDouglas J Kennett, Patricia M Lambert, John R Johnson, et al.
The Oncologist|October 27, 2007
FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphomaBhupinder S Mann, John R Johnson, Martin H Cohen, et al.
Journal of the National Cancer Institute|February 2, 2010
Review of oncology and hematology drug product approvals at the US Food and Drug Administration between July 2005 and December 2007Rajeshwari Sridhara, John R Johnson, Robert Justice, et al.
The Spine Journal : Official Journal of the North American Spine Society|November 12, 2003
Perioperative complications of lumbar instrumentation and fusion in patients with diabetes mellitusSteven D Glassman, Gary Alegre, Leah Carreon, et al.
The Oncologist|August 5, 2005
FDA drug approval summary: erlotinib (Tarceva) tabletsMartin H Cohen, John R Johnson, Yeh-Fong Chen, et al.
The Oncologist|June 22, 2005
FDA drug approval summary: pemetrexed for injection (Alimta) for the treatment of non-small cell lung cancerMartin H Cohen, John R Johnson, Yong-Cheng Wang, et al.
Oncology (Williston Park, N.Y.)|February 6, 2008
Erlotinib/gemcitabine for first-line treatment of locally advanced or metastatic adenocarcinoma of the pancreasAdrian M Senderowicz, John R Johnson, Rajeshwari Sridhara, et al.
Pageof 6